7月9日，Medline盘中下跌4.6%，报40.905美元/股，成交额1.09亿美元。
消息面上，尽管公司当日宣布与明尼阿波利斯医疗系统Allina Health达成核心供应商协议，但此前FDA连续两次发出警告信引发的监管阴云仍在发酵。FDA于5月28日向Medline发出警告信，指出其伊利诺伊州工厂存在严重违反成品药CGMP规定的行为，且该公司已因此面临证券欺诈调查。公司需在规定时限内回应FDA并提交整改计划，否则可能面临暂停出口证书等进一步执法措施。此外，医疗保健用品板块整体承压，艾利科技跌5.16%、库珀医疗跌2.84%、UFP技术跌3.78%，行业弱势进一步放大了个股跌幅。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.